Filing Flows › Sanara MedTech (SMTI) › R&D spending
Sanara MedTech (SMTI) R&D spending by quarter
Sanara MedTech's R&D spending was $1.2M in Q2 2026 (second quarter 2026), +52% from Q1 2026. Over the last 6 quarters it ranged from $760K (Q1 2026) to $2.0M (Q4 2025).
| Quarter | R&D spending | Q/Q | Y/Y |
|---|---|---|---|
| Q2 2026 | $1.2M | +52% | -8% |
| Q1 2026 | $760K | -63% | -32% |
| Q4 2025 | $2.0M | +98% | — |
| Q3 2025 | $1.0M | -18% | — |
| Q2 2025 | $1.3M | +13% | — |
| Q1 2025 | $1.1M | — | — |
Q2 2026 at a glance
Sanara MedTech, Q2 2026: revenue $28.1M (+9% year over year), operating margin 6.3%, net loss $453K, operating cash flow $2.0M. The chart follows the revenue to costs, profit and cash.
Questions
What is Sanara MedTech's R&D spending?
Sanara MedTech's R&D spending was $1.2M in Q2 2026 (second quarter 2026), +52% from Q1 2026.
How has Sanara MedTech's R&D spending changed?
Over the last 6 quarters it ranged from $760K (Q1 2026) to $2.0M (Q4 2025).